Revenue
2019
2020
2021
2022
2023
2024
2025
Benitec Biopharma Inc. (BNTC)
Price$12.68Cached quote
Net income
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $75,000 | $73,000 | $59,000 | $97,000 | $11.6M |
| Research & development | $18.3M | $15.6M | $12.8M | $11.3M | $7.0M | $3.0M | $4.6M |
| Operating expenses | $41.8M | $22.5M | $19.2M | $17.9M | $13.7M | $8.4M | $9.6M |
| Operating income | −$41.8M | −$22.5M | −$19.1M | −$17.9M | −$13.6M | −$8.3M | $2.6M |
| Operating margin | — | — | −25,441.33% | −24,457.53% | −23,044.07% | −8,537.11% | 22.36% |
| EBITDA | −$41.7M | −$22.4M | −$18.9M | −$17.7M | −$13.4M | −$8.1M | $2.7M |
| EBITDA margin | — | — | −25,260.00% | −24,228.77% | −22,652.54% | −8,341.24% | 23.73% |
| Net income | −$37.9M | −$21.8M | −$19.6M | −$18.2M | −$13.9M | −$8.3M | $2.6M |
| Net profit margin | — | — | −26,082.67% | −24,942.47% | −23,528.81% | −8,529.90% | 22.59% |
| Basic EPSper basic share | -$1.05 | -$1.22 | -$14.12 | -$37.88 | -$54.91 | -$137.70 | $51.85 |
| Diluted EPSper diluted share | -$1.05 | -$1.22 | -$14.12 | -$37.88 | -$54.91 | -$137.70 | $51.85 |
Owners
Reported shareholders
33.55%of listed shares
MONTANOVA CAPITAL, LLC11.55M shares · Jun 30, 2026
View holders
| Holder | % owned |
|---|---|
MONTANOVA CAPITAL, LLC | 33.55%11.55M shares |
Nantahala Capital Management, LLC | 8.65%2.98M shares |
Jupiter Topco LLC | 7.20%2.48M shares |
FRANKLIN RESOURCES INC | 7.01%2.41M shares |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 6.16%2.12M shares |
RA CAPITAL MANAGEMENT, L.P. | 5.38%1.85M shares |
BlackRock, Inc. | 4.09%1.41M shares |
Simplify Asset Management Inc. | 2.92%1.01M shares |
VANGUARD CAPITAL MANAGEMENT LLC | 2.77%954.53K shares |
INFINITUM ASSET MANAGEMENT, LLC | 2.68%923.01K shares |
MILLENNIUM MANAGEMENT LLC | 2.68%921.3K shares |
Alyeska Investment Group, L.P. | 2.18%750K shares |
SILVERARC CAPITAL MANAGEMENT, LLC | 1.98%679.83K shares |
Balyasny Asset Management L.P. | 1.89%650.5K shares |
GEODE CAPITAL MANAGEMENT, LLC | 1.78%611.74K shares |
AMERIPRISE FINANCIAL INC | 1.17%401.25K shares |
STATE STREET CORP | 1.10%377.97K shares |
MYDA Advisors LLC | 0.73%250K shares |
Schonfeld Strategic Advisors LLC | 0.68%235.36K shares |
AWM Investment Company, Inc. | 0.55%187.98K shares |
Percentages use 34.42M shares of this listed class outstanding on Jun 30, 2026.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Dec 29, 2025Form 4 | Cowen Aaron +3Director,TenPercentOwner | BuyCommon stock, par value $0.0001 per share · indirect | 11.6K | $13.44 | $155.7K | 1.85M |
| Dec 29, 2025Form 4 | Cowen Aaron +3Director,TenPercentOwner | BuyCommon stock, par value $0.0001 per share · indirect | 65.8K | $13.44 | $884.4K | 9.70M |
| Dec 26, 2025Form 4 | Cowen Aaron +3Director,TenPercentOwner | BuyCommon stock, par value $0.0001 per share · indirect | 2.5K | $13.10 | $33.0K | 1.84M |
| Dec 26, 2025Form 4 | Cowen Aaron +3Director,TenPercentOwner | BuyCommon stock, par value $0.0001 per share · indirect | 14.3K | $13.10 | $187.6K | 9.63M |
| Dec 23, 2025Form 4 | Cowen Aaron +3Director,TenPercentOwner | BuyCommon stock, par value $0.0001 per share · indirect | 7.4K | $12.85 | $95.1K | 1.83M |